Net Loss: Net loss attributable to common stockholders for the third quarter of 2024 was $ (3.1) million, or $ (1.92) per share, compared to net income of $0.5 million, or $4.86 per share, for the ...
A healthy brain balances “activate” and “inhibit” signaling in its neural microcircuitry, with the inhibitory signaling often provided by cell receptors for the neurotransmitter GABA. Unexpected ...
Barbiturates are central nervous system depressant drugs that have been used to treat seizures, insomnia, migraines, and more. However, they are not as commonly used today due to their side effects ...
Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced that it will present posters highlighting new ...
Bucillamine and NAC will be evaluated to determine the effect on GABA(A) receptor endocytosis and the ... Revive prioritizes its drug development efforts to take advantage of several regulatory ...